These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

955 related items for PubMed ID: 18836868

  • 41. Efficacy and safety of long-term continuous growth hormone treatment of children born small for gestational age.
    Hokken-Koelega A, van Pareren Y, Arends N, Boonstra V.
    Horm Res; 2004; 62 Suppl 3():149-54. PubMed ID: 15539818
    [Abstract] [Full Text] [Related]

  • 42. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
    Tauber M, Ester W, Auriol F, Molinas C, Fauvel J, Caliebe J, Nugent T, Fryklund L, Ranke MB, Savage MO, Clark AJ, Johnston LB, Hokken-Koelega AC, NESTEGG group.
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
    [Abstract] [Full Text] [Related]

  • 43. Growth hormone treatment of short children born small for gestational age: a US perspective.
    Chernausek SD.
    Horm Res; 2004 Sep; 62 Suppl 3():124-7. PubMed ID: 15539813
    [Abstract] [Full Text] [Related]

  • 44. Reduced levels of GH during GnRH analogue treatment in pubertal short girls born small for gestational age (SGA).
    van der Kaay DC, Rose SR, van Dijk M, Noordam C, van Rheenen E, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):914-9. PubMed ID: 19178519
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
    Garcia RA, Longui CA, Kochi C, Arruda M, Faria CD, Calliari LE, Monte O, Pachi PR, Saenger P.
    Horm Res; 2009 Jun; 72(5):275-80. PubMed ID: 19844113
    [Abstract] [Full Text] [Related]

  • 47. [Intrauterine growth retardation: diagnostic and therapeutic approach].
    Di Cesare Merlone A, Bozzola E, Cerbo RM, Rondini G.
    Minerva Pediatr; 2004 Apr; 56(2):183-8. PubMed ID: 15249902
    [Abstract] [Full Text] [Related]

  • 48. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD, Schweizer R, Schönau E, Binder G, Ranke MB.
    Horm Res; 2009 Apr; 72(1):38-45. PubMed ID: 19571558
    [Abstract] [Full Text] [Related]

  • 49. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS, Scheinowitz M, Laron Z.
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [Abstract] [Full Text] [Related]

  • 50. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T, Mulder P, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [Abstract] [Full Text] [Related]

  • 51. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board.
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
    [Abstract] [Full Text] [Related]

  • 52. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC, van Pareren Y, Sas T, Arends N.
    Horm Res; 2003 Aug; 60 Suppl 3():113-4. PubMed ID: 14671407
    [Abstract] [Full Text] [Related]

  • 53. Quality of life in adolescents born small for gestational age: does growth hormone make a difference?
    Bannink EM, van Pareren YK, Theunissen NC, Raat H, Mulder PG, Hokken-Koelega AC.
    Horm Res; 2005 Aug; 64(4):166-74. PubMed ID: 16205095
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Neurocognitive development in children experiencing intrauterine growth retardation and born small for gestational age: pathological, constitutional and therapeutic pathways.
    Noeker M.
    Horm Res; 2005 Aug; 64 Suppl 3():83-8. PubMed ID: 16439849
    [Abstract] [Full Text] [Related]

  • 57. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A, Simon D, Czernichow P.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [Abstract] [Full Text] [Related]

  • 58. [Growth hormone treatment in younger than six years of age short children born small for gestational age].
    Bergadá I, Blanco M, Keselman A, Domené HM, Bergadá C.
    Arch Argent Pediatr; 2009 Oct; 107(5):410-6. PubMed ID: 19809761
    [Abstract] [Full Text] [Related]

  • 59. Insulin sensitivity decreases in short children born small for gestational age treated with growth hormone.
    Bachmann S, Bechtold S, Bonfig W, Putzker S, Buckl M, Schwarz HP.
    J Pediatr; 2009 Apr; 154(4):509-13. PubMed ID: 19038401
    [Abstract] [Full Text] [Related]

  • 60. Longitudinal follow-up of height up to five years of age in infants born preterm small for gestational age; comparison to full-term small for gestational age infants.
    Itabashi K, Mishina J, Tada H, Sakurai M, Nanri Y, Hirohata Y.
    Early Hum Dev; 2007 May; 83(5):327-33. PubMed ID: 16930872
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.